+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Plasma matrix metalloproteinases, cytokines and angiogenic factors in moyamoya disease

Plasma matrix metalloproteinases, cytokines and angiogenic factors in moyamoya disease

Journal of Neurology, Neurosurgery, and Psychiatry 81(6): 673-678

To document the expression patterns of various matrixins, cytokines and angiogenic factors in plasma to assess their involvement in the pathogenesis of moyamoya disease (MMD). This study included plasma samples from 20 MMD patients and nine healthy individuals. The plasma concentration of five matrix metalloproteinases (MMP-1, MMP-2, MMP-3, MMP-9, MMP-12), monocyte chemoattractant protein-1 (MCP-1), resistin, three interleukins (IL-1beta, IL-6, IL-8), tumour necrosis factor-alpha, vascular endothelial growth factor (VEGF), platelet-derived growth factor BB (PDGF-BB) and basic fibroblast growth factor was determined using multianalyte profiling systems. The concentration of the tissue inhibitors of metalloproteinase (TIMP-1 and TIMP-2) was measured using ELISA. Gelatin zymography for MMP-2 and MMP-9 was also performed. MMD patients exhibited significantly higher plasma concentrations of MMP-9, MCP-1, IL-1beta, VEGF and PDGF-BB, and lower plasma concentrations of MMP-3, TIMP-1 and TIMP-2 compared with healthy controls. Significant correlations were found among MMP-9, MCP-1, VEGF, PDGF-BB and TIMP-2 in MMD patients. There were distinctive expression patterns of matrixins, cytokines and angiogenic factors in MMD patients, which seemed to correlate with disease pathogenesis. The balance between MMPs and TIMPs was disrupted in MMD and correlated with disease pathogenesis. Increased plasma levels of MCP-1 and VEGF in MMD patients may play a role in the recruitment of vascular progenitor cells and in the formation of collateral vessels.

(PDF emailed within 0-6 h: $19.90)

Accession: 055020862

Download citation: RISBibTeXText

PMID: 19965844

DOI: 10.1136/jnnp.2009.191817

Related references

Matrix metalloproteinases, tissue inhibitors of matrix metalloproteinases and angiogenic cytokines in peripheral blood of patients with thyroid cancer. Thyroid 12(8): 655-662, 2002

Roles of pro-angiogenic and anti-angiogenic factors as well as matrix metalloproteinases in healing of NSAID-induced small intestinal ulcers in rats. Life Sciences 93(12-14): 441-447, 2014

Differential regulation of the expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases by cytokines and growth factors in bovine endometrial stromal cells and trophoblast cell line BT-1 in vitro. Biology of Reproduction 68(4): 1276-1281, 2003

Competitive RNA templates for detection and quantitation of growth factors, cytokines, extracellular matrix components and matrix metalloproteinases by RT-PCR. Biotechniques 20(4): 670-674, 1996

Angiogenic factors in moyamoya disease. Stroke 27(12): 2160-2165, 1996

Aluminum oxide microdermabrasion induces transcription factors, cytokines, and matrix metalloproteinases that function in dermal extracellular matrix remodeling in human skin in vivo. Journal of Investigative Dermatology 122(3): A52, March, 2004

Proinflammatory cytokines and angiogenic and anti-angiogenic factors in vitreous of patients with proliferative diabetic retinopathy and eales' disease. Retina 28(6): 817-824, 2008

Zoledronic-acid-induced circulating level modifications of angiogenic factors, metalloproteinases and proinflammatory cytokines in metastatic breast cancer patients. Oncology 69(1): 35-43, 2005

Human dermal microvascular endothelial cells produce matrix metalloproteinases in response to angiogenic factors and migration. Journal of Investigative Dermatology 105(2): 170-176, 1995

Pathogenesis of pterygia: role of cytokines, growth factors, and matrix metalloproteinases. Progress in Retinal and Eye Research 23(2): 195-228, 2004

Expression of growth factors, cytokines and matrix metalloproteinases in frozen shoulder. Journal of Bone and Joint Surgery. British Volume 82(5): 768-773, 2000

Matrix metalloproteinases and angiogenic factors: predictors of survival after radical prostatectomy for clinically organ-confined prostate cancer?. American Journal of Pathology 177(5): 2216-2224, 2011

Bcr-abl-positive cells secrete angiogenic factors including matrix metalloproteinases and stimulate angiogenesis in vivo in Matrigel implants. Leukemia 16(6): 1160-1166, 2002

Molecules in blastocyst implantation. Role of matrix metalloproteinases, cytokines and growth factors. Journal of Reproductive Medicine 48(3): 137-147, 2003

Matrix metalloproteinases induction by pseudomonal virulence factors and inflammatory cytokines in vitro. Microbial Pathogenesis 31(6): 271-281, 2001